XPHYF News and Press, XPhyto Therapeutics Corp From 12/12/22

VANCOUVER, BC / ACCESSWIRE / December 12, 2022 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) is pleased to report that it has signed a non-binding term sheet (the "Term Sheet") for the acquisition of certain intellectual property assets and rights related...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 7, 2022 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT), is pleased to announce today that it has closed its non-broke...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 5, 2022 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT), in connection with the Company's news release dated Novem...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / November 29, 2022 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT), an international drug formulation and diagnostics c...

BioNxt Solution (CSE: BNXT) (OTC: XPHYF) (FSE: 4XT) , a bioscience accelerator focused on next-generation drug delivery and diagnostic and new active pharmaceutical ingredient investment opportunities, is reporting on its participation at the CPHI pharma conference in Frankfurt, Germany. Ea...

VANCOUVER, BC / ACCESSWIRE / November 21, 2022 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTC:XPHYF)(FSE:4XT) is pleased to report on a successful CPHI pharma conference in Frankfurt, Germany, attended by the BioNxt team earlier this month ("CPHI"). CPHI is the larges...

XPhyto Therapeutics ( OTCQB:XPHYF ) said Thursday it will change its corporate name from "XPhyto Therapeutics Corp." to "BioNxt Solutions Inc.," effective November 14, 2022. On the effective date of name change, the trading symbol will change from "XPHY" to "BNXT". The ...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has announced a name change. According to the company, effective next Monday, Nov. 14, 2022, the company’s name will change from XPhyto Therapeutics Corp. to BioNxt Solutions Inc. Along with the name change, the com...

VANCOUVER, BC / ACCESSWIRE / November 10, 2022 / XPhyto Therapeutics Corp. (" XPhyto " or the " Company ") (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) is pleased to announce that effective November 14, 2022, the Company's name will change from "XPhyto Therapeutics Corp." to " BioNxt Solutions Inc. ". A...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) today reported the results of its Rotigotine transdermal (“TDS”) patch human skin cadaver study and dissolution data. The company’s Rotigotine patch is based on the TDS platform technology developed by Vektor Ph...